Published in Obstet Gynecol on December 01, 2010
Vaginal hysterectomy: past, present, and future. Int Urogynecol J (2014) 2.14
Nationwide trends in the performance of inpatient hysterectomy in the United States. Obstet Gynecol (2013) 2.05
Use of guideline-based antibiotic prophylaxis in women undergoing gynecologic surgery. Obstet Gynecol (2013) 1.03
Costs and outcomes of abdominal, vaginal, laparoscopic and robotic hysterectomies. JSLS (2013) 1.01
Quality of care in humanitarian surgery. World J Surg (2011) 0.96
Safety and tolerance of radical hysterectomy for cervical cancer in the elderly. Gynecol Oncol (2014) 0.91
The impact of surgeon volume on perioperative outcomes in hysterectomy. JSLS (2014) 0.91
An economic analysis of robotically assisted hysterectomy. Obstet Gynecol (2014) 0.85
Trends and Factors Influencing Inpatient Prolapse Surgical Costs and Length of Stay in the United States. Female Pelvic Med Reconstr Surg (2016) 0.84
Failure to rescue after major gynecologic surgery. Am J Obstet Gynecol (2013) 0.81
Factors associated with 30-day hospital readmission after hysterectomy. Obstet Gynecol (2015) 0.80
Influence of treatment center and hospital volume on survival for locally advanced cervical cancer. Gynecol Oncol (2015) 0.79
Improving Patient Outcomes in Gynecology: The Role of Large Data Registries and Big Data Analytics. J Minim Invasive Gynecol (2015) 0.77
Non-decent Vaginal Hysterectomy in Rural Setup of MP: A Poor Acceptance. J Obstet Gynaecol India (2016) 0.75
The Impact of Individual Surgeon Volume on Hysterectomy Costs. JSLS (2017) 0.75
Association between Fellowship Training, Surgical Volume, and Laparoscopic Suturing Techniques among Members of the American Association of Gynecologic Laparoscopists. Minim Invasive Surg (2016) 0.75
Safely Increase the Minimally Invasive Hysterectomy Rate: A Novel Three-Tiered Preoperative Categorization System Can Predict the Difficulty for Benign Disease. Perm J (2015) 0.75
Determining Optimal Route of Hysterectomy for Benign Indications: Clinical Decision Tree Algorithm. Obstet Gynecol (2016) 0.75
Why do we argue about route of hysterectomy? A call for dialogue. Int Urogynecol J (2016) 0.75
Open abdominal surgery: a diminishing art. Int Urogynecol J (2015) 0.75
Impact of a Fellowship-Trained Minimally Invasive Gynecologic Surgeon on Patient Outcomes. JSLS (2017) 0.75
The Role of the Surgeon on Outcomes of Vaginal Prolapse Surgery With Mesh. Female Pelvic Med Reconstr Surg (2017) 0.75
Robotically assisted vs laparoscopic hysterectomy among women with benign gynecologic disease. JAMA (2013) 4.67
Perioperative comparative effectiveness of anesthetic technique in orthopedic patients. Anesthesiology (2013) 3.45
Trabectedin plus pegylated liposomal Doxorubicin in recurrent ovarian cancer. J Clin Oncol (2010) 3.33
Replication of lung cancer susceptibility loci at chromosomes 15q25, 5p15, and 6p21: a pooled analysis from the International Lung Cancer Consortium. J Natl Cancer Inst (2010) 3.18
Evaluation of third-degree and fourth-degree laceration rates as quality indicators. Obstet Gynecol (2015) 2.64
Comparative effectiveness of robotic versus laparoscopic hysterectomy for endometrial cancer. J Clin Oncol (2012) 2.59
Identification of copy number gain and overexpressed genes on chromosome arm 20q by an integrative genomic approach in cervical cancer: potential role in progression. Genes Chromosomes Cancer (2008) 2.29
Resource utilization for ovarian cancer patients at the end of life: how much is too much? Gynecol Oncol (2005) 2.26
Genome-wide association analysis identifies new lung cancer susceptibility loci in never-smoking women in Asia. Nat Genet (2012) 2.26
Latest research and treatment of advanced-stage epithelial ovarian cancer. Nat Rev Clin Oncol (2013) 2.24
Trends in relative survival for ovarian cancer from 1975 to 2011. Obstet Gynecol (2015) 2.22
Uptake and economic impact of first-cycle colony-stimulating factor use during adjuvant treatment of breast cancer. J Clin Oncol (2012) 2.21
Society of Gynecologic Oncologists Education Committee statement on risk assessment for inherited gynecologic cancer predispositions. Gynecol Oncol (2007) 2.20
Lymphadenectomy influences the utilization of adjuvant radiation treatment for endometrial cancer. Am J Obstet Gynecol (2011) 2.19
Racial disparities for uterine corpus tumors: changes in clinical characteristics and treatment over time. Cancer (2009) 2.15
Surgical-pathological predictors of disease-free survival and risk groupings for IB2 cervical cancer: do the traditional models still apply? Gynecol Oncol (2004) 2.08
Nationwide trends in the performance of inpatient hysterectomy in the United States. Obstet Gynecol (2013) 2.05
Prognostic significance of adenocarcinoma histology in women with cervical cancer. Gynecol Oncol (2012) 1.98
Comparative performance of the 2009 international Federation of gynecology and obstetrics' staging system for uterine corpus cancer. Obstet Gynecol (2010) 1.98
Trends and Predictors of Cerclage Use in the United States From 2005 to 2012. Obstet Gynecol (2015) 1.96
Prophylactic and risk-reducing bilateral salpingo-oophorectomy: recommendations based on risk of ovarian cancer. Obstet Gynecol (2010) 1.94
The 5p15.33 locus is associated with risk of lung adenocarcinoma in never-smoking females in Asia. PLoS Genet (2010) 1.90
Predictors of massive blood loss in women with placenta accreta. Am J Obstet Gynecol (2011) 1.86
Prevalence of defective DNA mismatch repair and MSH6 mutation in an unselected series of endometrial cancers. Proc Natl Acad Sci U S A (2003) 1.83
Primary therapy for early-stage cervical cancer: radical hysterectomy vs radiation. Am J Obstet Gynecol (2009) 1.75
Metabolomic analysis of livers and serum from high-fat diet induced obese mice. J Proteome Res (2010) 1.75
Trends in hospital volume and patterns of referral for women with gynecologic cancers. Obstet Gynecol (2013) 1.72
Use of complementary and alternative medicine among women with gynecologic cancers. Gynecol Oncol (2002) 1.72
The impact of sleep apnea on postoperative utilization of resources and adverse outcomes. Anesth Analg (2014) 1.69
Cervical carcinoma in the elderly: an analysis of patterns of care and outcome. Cancer (2005) 1.68
Extensively drug-resistant tuberculosis in South Korea: risk factors and treatment outcomes among patients at a tertiary referral hospital. Clin Infect Dis (2008) 1.67
Defining the limits of radical cytoreductive surgery for ovarian cancer. Gynecol Oncol (2011) 1.66
Management of symptomatic ascites in recurrent ovarian cancer patients using an intra-abdominal semi-permanent catheter. Am J Hosp Palliat Care (2002) 1.65
Microenvironments in tuberculous granulomas are delineated by distinct populations of macrophage subsets and expression of nitric oxide synthase and arginase isoforms. J Immunol (2013) 1.62
Sleep apnea and total joint arthroplasty under various types of anesthesia: a population-based study of perioperative outcomes. Reg Anesth Pain Med (2013) 1.62
Effect of surgical volume on outcomes for laparoscopic hysterectomy for benign indications. Obstet Gynecol (2012) 1.58
Incidence and predictors of bowel obstruction in elderly patients with stage IV colon cancer: a population-based cohort study. JAMA Surg (2013) 1.57
Penetrance and expressivity of MSH6 germline mutations in seven kindreds not ascertained by family history. Am J Hum Genet (2004) 1.57
Regionalization of care for obstetric hemorrhage and its effect on maternal mortality. Obstet Gynecol (2010) 1.56
Scientific evidence underlying the American College of Obstetricians and Gynecologists' practice bulletins. Obstet Gynecol (2011) 1.55
Trends in surgical mesh use for pelvic organ prolapse from 2000 to 2010. Obstet Gynecol (2012) 1.55
A prospective study evaluating the clinical relevance of a chemoresponse assay for treatment of patients with persistent or recurrent ovarian cancer. Gynecol Oncol (2013) 1.54
Contemporary management of endometrial cancer. Lancet (2012) 1.51
Genetic diversity of Mycobacterium tuberculosis isolates from a tertiary care tuberculosis hospital in South Korea. J Clin Microbiol (2009) 1.49
Comparative effectiveness research in oncology methodology: observational data. J Clin Oncol (2012) 1.49
Variation in ovarian conservation in women undergoing hysterectomy for benign indications. Obstet Gynecol (2013) 1.46
Insertion of the ProSeal laryngeal mask airway is more successful with the 90 degrees rotation technique. Can J Anaesth (2010) 1.46
Utilization of critical care services among patients undergoing total hip and knee arthroplasty: epidemiology and risk factors. Anesthesiology (2012) 1.41
Postpartum sterilization: small incision, big complication. Obstet Gynecol (2008) 1.40
Lack of benefit of concurrent chemotherapy in patients with cervical cancer and negative lymph nodes by FDG-PET. Int J Radiat Oncol Biol Phys (2005) 1.39
Nanog signaling in cancer promotes stem-like phenotype and immune evasion. J Clin Invest (2012) 1.37
Frequent HOXA11 and THBS2 promoter methylation, and a methylator phenotype in endometrial adenocarcinoma. Clin Cancer Res (2003) 1.36
The delayed leaf senescence mutants of Arabidopsis, ore1, ore3, and ore9 are tolerant to oxidative stress. Plant Cell Physiol (2004) 1.33
miR-206 regulates brain-derived neurotrophic factor in Alzheimer disease model. Ann Neurol (2012) 1.32
Integrative genomics analysis of chromosome 5p gain in cervical cancer reveals target over-expressed genes, including Drosha. Mol Cancer (2008) 1.29
SGO White Paper on ovarian cancer: etiology, screening and surveillance. Gynecol Oncol (2010) 1.27
Comparative perioperative outcomes associated with neuraxial versus general anesthesia for simultaneous bilateral total knee arthroplasty. Reg Anesth Pain Med (2012) 1.25
Fertility preservation in young women with epithelial ovarian cancer. Cancer (2009) 1.24
The RAV1 transcription factor positively regulates leaf senescence in Arabidopsis. J Exp Bot (2010) 1.22
Activation of Akt as a mechanism for tumor immune evasion. Mol Ther (2008) 1.22
Quality of perioperative venous thromboembolism prophylaxis in gynecologic surgery. Obstet Gynecol (2011) 1.21